Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
30.75
+0.83 (2.77%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Tectonic Therapeutic Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Tectonic Therapeutic stock has a consensus rating of "Strong Buy" and an average price target of $77.56. The average 1-year stock price forecast is 152.23% higher than the current stock price, while the lowest is $60 (+95.12%) and the highest is $93 (+202.44%).
Price Target: $77.56 (+152.23%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Tectonic Therapeutic stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 9 | 9 | 9 | 9 | 9 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Reiterates $80 | Buy | Reiterates | $80 | +160.16% | Sep 1, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $76 | Buy | Maintains | $76 | +147.15% | Aug 31, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $88 | Buy | Maintains | $88 | +186.18% | Aug 31, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $85 | Buy | Reiterates | $85 | +176.42% | Aug 27, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $60 | Buy | Maintains | $60 | +95.12% | Aug 10, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.44
EPS Next Year
-6.94
from -5.44
EPS and Forward PE are based on non-GAAP adjusted numbers.